BioCentury

6:11 PM GMT, May 3, 2017
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Distillery Therapeutics

Endocrine / Metabolic

INDICATION: Diabetes

Cell culture and mouse experiments identified oxyindole-based inhibitors of PGC-1α gluconeogenic activity that

Read the full 147 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.